Xospata (Gilteritinib Tablet) 40mg

Xospita 40mg tablets contain gilteritinib, a prescription medication used for certain blood cancers. This oral therapy helps manage disease progression in adults with specific types of leukemia. Store at room temperature away from moisture and heat.

Strength

40mg

Pack Size

90s

Storage

Ambient

Manufacturer / TM Owner

Astellas USA Inc

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Gilteritinib is primarily used to treat adults with relapsed or refractory acute myeloid leukemia (AML) who have a specific genetic mutation. It works by targeting cancer cells to slow disease progression. Patients often ask what is Xospita 40mg used for, and it is indicated for FLT3 mutation-positive AML after other treatments have not worked. This medication is part of targeted therapy approaches for blood cancers.

Side Effects

Gilteritinib helps control cancer progression by interfering with signals that promote tumor growth. Patients may notice improved energy levels and reduced symptoms over time. Common effects include mild nausea or fatigue, which vary by individual. Regular monitoring is recommended to assess response and manage any changes.

Precautions & Warnings

Keep Xospita 40mg tablets in their original container to protect from moisture. Store at room temperature and avoid exposure to extreme heat or cold. Do not use if the seal is broken or the tablets appear damaged. Always follow your healthcare provider’s instructions for handling and disposal.

Avoid Interactions

Gilteritinib may interact with other medications, including certain antifungals, antibiotics, and heart rhythm drugs. Avoid grapefruit products as they can increase gilteritinib levels in the blood. Inform your doctor about all prescription, over-the-counter, and herbal products you use. Alcohol use should be discussed with a healthcare professional.

Frequently Asked Questions

Xospita 40mg is used to treat adults with relapsed or refractory acute myeloid leukemia (AML) that has a FLT3 mutation.

Store Xospita 40mg tablets at room temperature in their original container, away from moisture and heat.

Some medications may interact with gilteritinib; consult your doctor before combining treatments, including over-the-counter products.

Common effects may include nausea, fatigue, or diarrhea; report persistent symptoms to your healthcare provider.

No, Xospita 40mg is a prescription medication and requires a doctor’s authorization to obtain.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.